# EVDI

NDC: 60505-6423
Generic name: Trabectedin
Labeler / Manufacturer: Apotex Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20260630

FDA application: NDA220837

## Active ingredients

- TRABECTEDIN: .05 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-6423"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-6423
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1d50f5c-4202-27f3-4798-a9708114ddea